Source:http://linkedlifedata.com/resource/pubmed/id/11292118
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2001-4-6
|
pubmed:abstractText |
Leakage of plasma proteins into the alveoli inhibits pulmonary surfactant function and worsens respiratory failure. Surfactant protein B (SP-B), is essential for surfactant function, but the N-terminal domain of human SP-B (residues 1.25, SP-B1-25) can mimic the biophysical properties of full length SP-B1-78 in vitro. The authors compared the function and inhibition resistance of synthetic surfactant preparations containing SP-B analogues to a natural bovine surfactant preparation "Survanta". Eight groups of eight rats were lavaged to induce surfactant deficiency, fibrinogen was instilled as a surfactant inhibitor, and then they were rescued with exogenous surfactant. Five experimental surfactants were formulated by mixing 3% SP-B1-78, or an equimolar amount of SP-B1-25 and/or 1% palmitoylated surfactant protein C (SP-C)1-35, into a standard phospholipid (PL) mixture: B1-78, B1-25, C1-35, B1-78+C1-35, and B1-25+C1-35 surfactant preparations. Survanta was used as a positive control and PL and no treatment as a negative control. Lung function was assessed during a 2-h period using arterial blood gas and lung compliance measurements. Rats treated with B1-25+C1-35 surfactant and Survanta maintained the highest oxygenation and lung compliance values throughout the experiments. The surfactants could be ranked as B1-25+C1-35 surfactant and Survanta >B1-25 and B1-78+C1-35 surfactants >others. Because the N-terminal domain of surfactant protein B1-25 can improve inhibition resistance, it may be able to substitute for surfactant protein B in exogenous surfactant preparations.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors,
http://linkedlifedata.com/resource/pubmed/chemical/Proteolipids,
http://linkedlifedata.com/resource/pubmed/chemical/Pulmonary Surfactant-Associated...,
http://linkedlifedata.com/resource/pubmed/chemical/Pulmonary Surfactants,
http://linkedlifedata.com/resource/pubmed/chemical/SFTPC protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Sftpc protein, rat,
http://linkedlifedata.com/resource/pubmed/chemical/beractant,
http://linkedlifedata.com/resource/pubmed/chemical/surfactant protein B propeptide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1129-33
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11292118-Animals,
pubmed-meshheading:11292118-Biological Agents,
pubmed-meshheading:11292118-Bronchoalveolar Lavage,
pubmed-meshheading:11292118-Drug Combinations,
pubmed-meshheading:11292118-Lung Compliance,
pubmed-meshheading:11292118-Male,
pubmed-meshheading:11292118-Peptides,
pubmed-meshheading:11292118-Protein Precursors,
pubmed-meshheading:11292118-Proteolipids,
pubmed-meshheading:11292118-Pulmonary Gas Exchange,
pubmed-meshheading:11292118-Pulmonary Surfactant-Associated Protein C,
pubmed-meshheading:11292118-Pulmonary Surfactants,
pubmed-meshheading:11292118-Rats,
pubmed-meshheading:11292118-Rats, Sprague-Dawley
|
pubmed:year |
2000
|
pubmed:articleTitle |
Comparison of functional efficacy of surfactant protein B analogues in lavaged rats.
|
pubmed:affiliation |
Harbor-(University of California) Research and Education Institute, Torrance & Dept of Pediatrics, Charles R. Drew University of Medicine & Science, Los Angeles, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|